Rare disease_KUNTUO

Top

Accurately Break the Dilemma of No Available Drugs
Diving into clinical development for rare diseases and providing customized support
Accelerating Clinical Studies in Rare Diseases
Accelerating Clinical Studies in Rare Diseases
Rare diseases refer to those which have low occurrence but are complicated, mainly caused by genetic defects (such as spinal muscular atrophy and Fabry disease). In studies for rare diseases, to fulfill patients’ unmet needs has been advancing scientific breakthroughs and treatments. Each study needs an empathetic and professional team to handle the complexity and deal with the unpredicted issues. Kun Tuo is to provide clinical development services involving full lifecycles and settle the recruitment difficulty through the IQVIA global patient community network. The adaptive trial design will be adopted to cope with the challenges of small sample size and take every effort to benefit patients of rare diseases with breakthrough therapies.
CGT Full-cycle Clinical Study Solutions

Post-marketing studies

Services for post-marketing real world evidence (RWE) studies

Submission of registration

NDA and MAA material submission in multiple tiers

Phase II to III

Phase II/III clinical studies
Validation of clinical study protocol
Monitoring of clinical trials
International lab service
Patient recruitment and retention
technical services and studies - wearable devices and connected devices

Phase I

Multiple services for clinical studies in the early stages with support of innovative data

Development plan

Clinical development strategy
Clinical trial design
Development management counseling

Customize Your Clinical Study Protocol